Home>drugs by ailments>Breast cancer>fulvestrant

Fulvestrant

Information about Fulvestrant

Fulvestrant Uses

Fulvestrant is used in the treatment of breast cancer.

How Fulvestrant works

Fulvestrant blocks the action of estrogen on breast cancer cells. This can lower or stop the growth of some breast cancer cells that need estrogen to grow.

Common side effects of Fulvestrant

Injection site reaction, Headache, Vomiting, Allergic reaction, Nausea1a, Diarrhea, Urinary tract infection, Weakness

CONTENT DETAILS

Written By

Dr. Anuj Saini

MMST, MBBS

Reviewed By

Dr. Ashish Ranjan

MD (Pharmacology), MBBS

Last updated

18 Feb 2020 | 11:51 AM (UTC)

We provide you with authentic, trustworthy and revelant information

Want to know more

Available Medicine for Fulvestrant

Expert advice for Fulvestrant

Fulvestrant is used for the treatment of hormone dependent breast cancer.
It should only be taken by women who have undergone menopause and cannot become pregnant.
It is given as a slow injection into the muscles (intramuscular) of your buttock.
Inform your doctor if you have any bleeding disorder, kidney or liver disease or if you are receiving any medicines to prevent blood clots.
Do not take Fulvestrant if you are pregnant or breastfeeding.

Frequently asked questions for Fulvestrant

Fulvestrant

Q. What is Fulvestrant and what is it used for?

Fulvestrant is a medicine, which is used to treat breast cancer in women who have gone through menopause.

Q. How and in what dose should I use Fulvestrant?

Your doctor would advise you the exact dose of this medicine. It is given as a slow (1 to 2 minutes) intramuscular (deep into the muscle) injection into your buttocks. It is administered by a medical healthcare professional only.

Q. What are the common side effects of using Fulvestrant?

The common side effects associated with this medicine are headache, vomiting, urinary tract infection, diarrhea, vaginal bleeding, low platelets count and back pain. If any of these side effects bother you, consult with your doctor.